# Top 50 Life Science Startup Investors in Asia in October 2023

## Hillhouse Capital Group
- Type: VC Fund
- Location: Changyang, Beijing, China
- Relevant deals: 6
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Software

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

## Prox Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 5
- Stages: Seed, Series A
- Focus: Medical, Biotechnology, Health Care

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

## Sequoia Capital China
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 5
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Artificial Intelligence

We help founders build enduring companies.

## EFung Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

## Osaka University Venture Capital
- Type: VC Fund
- Location: Osaka, Osaka, Japan
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Manufacturing

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.
The firm was founded in 2014 and based in Osaka, Japan.

## Huagai Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 4
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

## Qiming Venture Partners
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Health Care, Medical, Biotechnology

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

## Legend Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Health Care, Biotechnology, Medical

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

## Entrepreneurship Relay Group
- Type: VC Fund
- Location: Yangpu, Hainan, China
- Relevant deals: 3
- Stages: Series A, Angel, Series C
- Focus: Medical, Life Science, Biotechnology

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

## EDBI
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 3
- Stages: Series C, Series B, Series D
- Focus: Biotechnology, Software, Health Care

EDBI is a premier Asian investor with headquarters in Singapore.

## Anzu Partners
- Type: VC Fund
- Location: Washington, District of Columbia, United States
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Biotechnology, Manufacturing, Software

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

## Mitsubishi UFJ Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 3
- Stages: Series B, Series A
- Focus: Software, Health Care, Information Technology

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

## SMBC Venture Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Health Care, Information Technology, Software

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

## Nippon Venture Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Software, Health Care, Information Technology

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

## BioVenture
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Health Care, Medical, Biotechnology

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

## ULTIMA
- Type: VC Fund
- Location: Chengdu, Sichuan, China
- Relevant deals: 2
- Stages: Angel, Series A
- Focus: Hardware, Software, Agriculture

ULTIMA is an investment management firm.

## WuXi AppTec
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Pharmaceutical, Health Care

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

## Highlight Capital
- Type: VC Fund
- Location: Nanjin, Jiangsu, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

## MiraclePlus
- Type: VC Fund
- Location: Haidian, Beijing, China
- Relevant deals: 2
- Stages: Seed, Angel, Pre-Seed
- Focus: Artificial Intelligence, Software, Information Technology

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

## Eisai
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

## Orient Securities Capital Investment
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series D, Series C
- Focus: Health Care, Manufacturing, Software

Orient Securities Capital Investment is an private equity fund business platform.

## Green Pine Capital Partners
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Angel, Series B
- Focus: Artificial Intelligence, Manufacturing, Software

Green Pine Capital Partners is a venture capital firm.

## Oriental Fortune Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, E-Commerce

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

## Nissay Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Health Care, Internet, Medical

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

## Loyal Valley Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm with strong entrepreneurial culture that invests in middle market companies positioned to benefit from the secular industry transformations in China. With over US$1.6 billion of assets under management, LVC mainly focuses on the following segments: Consumer (TMT,Internet, and Education), Healthcare, and Advanced Manufacturing. Our investment process is characterized by in-depth top-down and bottom-up fundamental research to uncover secular themes and utilize extensive industry mapping to deploy capital in a high conviction and disciplined approach. We pride ourselves as a trusted influential shareholder relentlessly focused on active value creation and accelerating growth via strategic initiatives through our extensive network of business leaders in China. LVC manages capital on behalf of international institutional investors such as sovereign wealth funds, funds of funds, private banks, and family offices, as well as elite entrepreneurs and founders of China’s Fortune 500 enterprises.LVC was founded in 2015 by Andy Lin, an experienced investor and accomplished entrepreneur. He is the founder of China Universal Asset Management (“CUAM”), one of China’s largest equity investor and asset manager with over US$100B in AUM, known for its industry leading research and award-winning investment records.

## BOHE Angel Fund
- Type: VC Fund
- Location: Suzhou, Jiangsu, China
- Relevant deals: 2
- Stages: Angel, Seed, Series A
- Focus: Health Care, Medical, Biotechnology

BOHE Angel Fund is an investment Fund.

## CentreGold Capital
- Type: VC Fund
- Location: Fremont, California, United States
- Relevant deals: 2
- Stages: Seed, Series A, Angel
- Focus: Internet, Medical Device, Artificial Intelligence

Our team invests in early-stage digital health and consumer startups at CentreGold Capital. 

## Incubate Fund
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Information Technology, E-Commerce

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

## Mizuho Capital
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Information Technology, Software, Internet

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

## SBI Investment
- Type: VC Fund
- Location: Minato, Chiba, Japan
- Relevant deals: 2
- Stages: Series B, Series A
- Focus: Financial Services, Information Technology, Software

SBI Investment supports the business development and growth of private venture companies through fund investment.

## Huimei Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

## Sherpa Venture Capital
- Type: VC Fund
- Location: Beijing, Beijing, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

## CD Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Angel
- Focus: Health Care, Biotechnology, Medical Device

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

## Senshu Ikeda Capital
- Type: VC Fund
- Location: Osaka, Osaka, Japan
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Internet, Information Technology

Senshu Ikeda Capital offers financial consultancy services.

## Eight Roads Ventures
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Software, Health Care, Information Technology

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

## Bits x Bites
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Food and Beverage, Food Processing

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

## Real Tech Japan
- Type: VC Fund
- Location: Sumida, Tokyo, Japan
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Manufacturing, Biotechnology, Robotics

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization).
The firm was founded in 2014 and based in Tokyo, Japan.

## Med-Fine Capital
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Health Care, Biotechnology, Medical

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

## Lilly Asia Ventures
- Type: VC Fund
- Location: Shanghai, Shanghai, China
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. 

## Lucion
- Type: VC Fund
- Location: Jinan, Shandong, China
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Medical, Manufacturing

Lucion is an influential professional venture capital institute.

## ASBV
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 2
- Stages: Series A, Seed, Angel
- Focus: Health Care, Medical, Biotechnology

ASBV focuses on early and mid-term venture capital investments.

## Anhui High-tech Industry Investment
- Type: VC Fund
- Location: Hefei, Anhui, China
- Relevant deals: 1
- Stages: Angel
- Focus: Medical, Health Care, Life Science

Anhui High-tech Industry Investment is engaged in high-tech industry investment and related derivative business.

## Tsing-Yuan Capital
- Type: VC Fund
- Location: Shenzhen, Guangdong, China
- Relevant deals: 1
- Stages: Series A, Angel, Series B
- Focus: Manufacturing, Health Care, E-Commerce

Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.

## Kaitai Capital
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 1
- Stages: Series A, Angel, Seed
- Focus: Biotechnology, Health Care, Pharmaceutical

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

## SDIC Venture Capital
- Type: VC Fund
- Location: Xicheng, Hebei, China
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Manufacturing, Biotechnology, Health Care

ounded in 2016, SDIC Venture Capital Co., Ltd. (SDICVC) is a fund management company founded by the State Development and Investment Corp. (SDIC), under a market driven governance structure. SDICVC currently manages four funds, with total asset under management at RMB 14 Billion.SDICVC puts into practice the marketization and industrializationof the nation’s scientific and technological achievements, focusing on an investment strategy of "serving the national innovation strategy and focusing on the transformation of scientific and technological achievements". SDICVC puts its expertise and experience to work to achieve its goals of policy orientation and return on investment, faithfully implementing the national development strategy, striving to realize the synergy between the government, the society and the market, realizing its positioning as "an ideal, trustworthy, respected, influential partner” and its role as a leading professional venture fund management institution.

## Hiroaki Kitano
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Angel, Debt Financing
- Focus: Health Care, Information Technology, Fitness

Hiroaki Kitano is the SVP at Softbank Mobile. He attended Waseda University.

## Alibaba Group
- Type: VC Fund
- Location: Hangzhou, Zhejiang, China
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: E-Commerce, Internet, Software

Alibaba Group’s mission is to make it easy to do business anywhere. They enable businesses to transform the way they market, sell, operate, and improve their efficiencies. They provide the technology infrastructure and marketing reach to help merchants, brands, and other businesses to leverage the power of new technology to engage with theirusers and customers and operate in a more efficient way.Their businesses are comprised of core commerce, cloud computing, digital media and entertainment, and innovation initiatives. In addition, Ant Financial, a company in which they have agreed to acquire a 33% equity stake, provides payment and financial services to consumers and merchants on their platforms. An ecosystem has developed around their platforms and businesses that consists of consumers, merchants, brands, retailers, other businesses, third-party service providers, and strategic alliance partners.

## Kunlun Capital
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Medical, Genetics

Kunlun Capital is a value-oriented and fundamentally driven family office. We do not manage external funds.

## Fujifilm
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Biotechnology, Medical Device, Medical

Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.

## Hana Financial Investment
- Type: VC Fund
- Location: Seoul, Seoul-t'ukpyolsi, South Korea
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Information Technology, FinTech, Financial Services

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co